Your browser doesn't support javascript.
loading
Nanovaccine that activates the NLRP3 inflammasome enhances tumor specific activation of anti-cancer immunity.
Manna, Saikat; Maiti, Sampa; Shen, Jingjing; Weiss, Adam; Mulder, Elizabeth; Du, Wenjun; Esser-Kahn, Aaron P.
Afiliação
  • Manna S; Pritzker School of Molecular Engineering, University of Chicago, 5640 S. Ellis Ave., Chicago, IL 60637, USA.
  • Maiti S; Pritzker School of Molecular Engineering, University of Chicago, 5640 S. Ellis Ave., Chicago, IL 60637, USA; Department of Chemistry and Biochemistry, Science of Advanced Material, Central Michigan University, Mount Pleasant, MI 48858, United States.
  • Shen J; Pritzker School of Molecular Engineering, University of Chicago, 5640 S. Ellis Ave., Chicago, IL 60637, USA.
  • Weiss A; Pritzker School of Molecular Engineering, University of Chicago, 5640 S. Ellis Ave., Chicago, IL 60637, USA; Department of Chemistry, University of Chicago, 5735 S Ellis Ave., Chicago, IL 60637, USA.
  • Mulder E; Pritzker School of Molecular Engineering, University of Chicago, 5640 S. Ellis Ave., Chicago, IL 60637, USA.
  • Du W; Department of Chemistry and Biochemistry, Science of Advanced Material, Central Michigan University, Mount Pleasant, MI 48858, United States.
  • Esser-Kahn AP; Pritzker School of Molecular Engineering, University of Chicago, 5640 S. Ellis Ave., Chicago, IL 60637, USA. Electronic address: aesserkahn@uchicago.edu.
Biomaterials ; 296: 122062, 2023 05.
Article em En | MEDLINE | ID: mdl-36863071

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas Anticâncer / Nanopartículas / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas Anticâncer / Nanopartículas / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article